DNA vaccine for Edwardsiella tarda and construction and application thereof
A technology of Edwards tarda, DNA vaccine, applied in Edwardian tarda DNA vaccine and its construction and application fields, to achieve the effect of high protection rate and high-efficiency immune protection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] The DNA vaccine is shown by the base sequence in the sequence table SEQ ID No.1.
[0024] Construction and preparation method of DNA vaccine:
[0025] 1) Construction of plasmid pPC2: Plasmid pCI-neo (purchased from Promega, USA) was digested with XhoI / SmaI, a 5.4kb fragment was recovered, and the oligonucleotide fragment L86 (5'-TCGAGATATCGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGACCC-3') was digested with T4DNA Ligase ligation, the ligation solution was transformed into E. coli DH5α, and cultured on LB solid medium containing anka penicillin (Ap, 100ug / ml) for 18-24 hours, picked 1 white transformant, and extracted the plasmid, which was pPC2.
[0026] The composition of the LB solid medium is by weight percentage: 1.0% peptone, 0.5% yeast powder, 1.0% sodium chloride, 1.5% agar, and 97.5% distilled water.
[0027] 2) Construction of plasmid pCFC: with Edwardsiella tarda TX1 as a template, PCR with the following primers: F8 (5'- AGTACT GCCACCATGGCACAAGTAATCAACACCA...
Embodiment 2
[0064] 1) DNA vaccine preparation:
[0065] The plasmid pPC2 obtained in step 1 of Example 1 was transformed into Escherichia coli and cultivated in the LB liquid medium containing 100ug / ml Ap for 18-24 hours. Company”, Beijing) to extract plasmid pPC2 for use;
[0066] Then the Edwardsiella tarda DNA vaccine shown in the nucleotide sequence in the sequence table 1 SEQ ID No.1 that is obtained in Example 1 is transformed into Escherichia coli and cultivated in the LB liquid medium containing 100ug / ml Ap for 18- Within 24 hours, use an endotoxin-free plasmid extraction kit (purchased from "Tiangen Biochemical Technology Co., Ltd.", Beijing) to extract the Edwardsiella tarda DNA vaccine shown in the base sequence in Sequence Table 1, SEQ ID No.1, and wait until use.
[0067] The above-mentioned obtained plasmid pPC2 and the Edwardsiella tarda DNA vaccine shown in the base sequence in SEQ ID No.1 of Sequence Table 1 were respectively dissolved in PBS to a concentration of 200ug...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com